MyAverix Finance
F · Healthcare
OCUPHIRE PHARMA DL-0001 (R3X1)
Biotechnology
OCUPHIRE PHARMA DL-0001 (R3X1) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $266.10M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for R3X1
OCUPHIRE PHARMA DL-0001 (R3X1) — FAQ
What is OCUPHIRE PHARMA DL-0001's market cap?
OCUPHIRE PHARMA DL-0001 (R3X1) has a reported market cap of $266.10M (data as of 2026-03-30).
What is R3X1's P/E ratio?
The price-to-earnings (P/E) ratio for OCUPHIRE PHARMA DL-0001 (R3X1) is 18.00 (data as of 2026-03-30).
Does OCUPHIRE PHARMA DL-0001 pay a dividend?
Dividend yield is not available in the current snapshot for OCUPHIRE PHARMA DL-0001 (R3X1). Check the MyAverix Finance app for the latest dividend data.
What sector is OCUPHIRE PHARMA DL-0001 in?
OCUPHIRE PHARMA DL-0001 (R3X1) is classified in the Healthcare sector (Biotechnology industry).
What exchange is R3X1 listed on?
R3X1 is listed on F.
What is OCUPHIRE PHARMA DL-0001's net margin?
OCUPHIRE PHARMA DL-0001 (R3X1) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.